Calcium crystal-associated diseases and miscellaneous crystals

Current Opinion in Rheumatology

Volumn 9, Issue 3, 1997, Pages 274-279

  Rull, Marina ^a,b,c  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CHOLESTEROL; HYDROXYAPATITE;

ANKYLOSING HYPEROSTOSIS; CHONDROCALCINOSIS; CRYSTALLIZATION; DIAGNOSTIC ACCURACY; EMBOLISM; HUMAN; PRIORITY JOURNAL; REVIEW; SPONDYLOEPIPHYSEAL DYSPLASIA;

APATITES; CALCIUM PYROPHOSPHATE; CHOLESTEROL; CHONDROCALCINOSIS; CRYOGLOBULINS; CRYSTALLIZATION; HUMANS; INFLAMMATION;

EID: 0030928326     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199705000-00017     Document Type: Review

References (52)

1. Schumacher HR: Pathology of crystal deposition disease. Rheum Dis Clin North Am 1988, 14:269-288.
2. Ryan LM, McCarty DJ: Calcium pyrophosphate crystal deposition disease, pseudogout, articular chondrocalcinosis. Arthritis and Allied Conditions, edn 11. Philadelphia: Lea & Febiger; 1989:1711-1736.
3. Beutler A, Rothfuss S, Clayburne G, Sieck M, Schumacher HR: Calcium pyrophosphate dihydrate crystal deposition in synovium. Arthritis Rheum 1993, 36:704-713.
4. Masuda I, Ishikawa K, Usuku G: A histologic and immunohistochemical study of calcium pyrophosphate dihydrate crystal deposition disease. Clin Orthop 1991, 263:272-287.
5. McDevitt CA, Webber RJ: The ultrastructure and biochemistry of meniscal cartilage. Clin Orthop 1990, 252:8-18.
6. Ota M, Oda Y, Nakaniski I: Immunohistochemical study on collagenous proteins and biophysical analysis of crystals in extraskeletal chondroma. Pathol Int 1995, 45:596-601. An immunohistochemical study showing the possible relationship of collagen type I and III with CPPD crystal deposition.
7. Derfus BA, Rachow JW, Mandel NS, Boskey AL, Buday H, Kushnagov VH, Ryan LM: Articular cartilage vesicles generate calcium pyrophosphate dihydrate-like crystals in vitro. Arthritis Rheum 1992, 35:231-240.
8. Ryan LM, Kurup IV, Derfus BA, Kudrnaryov VM: ATP-induced chondrocalcinosis. Arthritis Rheum 1992, 35:1520-1525.
9. Kranendonk S, Ryan L, Buday M, Lynch K, Derfus B: Human osteoarthritis vesicles generate both monoclinic calcium pyrophosphate dihydrate and apatite crystals in vitro. J Bone Joint Surg Am 1994, 18:502-503.
10. Derfus B, Steinberg M, Mandel N, Buday M, Daft L, Ryan L: Characterization of an additional articular cartilage vesicle fraction that generates calcium pyrophosphate dihydrate crystals in vitro. J Rheumatol 1995, 22:1514-1519.
11. Masuda I, Hamada J, Haas AL, Ryan LM, McCarty DJ: A unique ectonucleotide pyrophosphohydrolase associated with porcine chondrocyte-derived vesicles. J Clin Invest 1995, 95:699-704.
12. Cardenal A, Masuda I, Hass AL, McCarty DJ: Specificity of a porcine 127-kD nucleotide pyrophosphohydrolase for articular tissues. Arthritis Rheum 1996, 39:245-251. This study relates 127-kD NTPPPH to articular cartilage vesicles and describes its limited distribution to articular tissue.
13. Huang R, Rosenbach M, Vaugh R, Provedini D, Rebbe N, Hickman S, Goding J, Terkeltaub R: Expression of the murine plasma cell nucleotide pyrophosphohydrolase PC-1 is shared by human liver, bone and cartilage cells. J Clin Invest 1994, 94:560-567.
14. Park W, Masuda I, Cardenal-Escarena A, Palmer WP, McCarty DJ: Generation of inorganic pyrophosphate from extracellular adenosine triphosphate by human serum and plasma. J Rheumatol 1996, 23:1233-1236. This is the first study quantifying PPi production from extracellular ATP in human plasma and serum, concluding that PPi is the major product of ATP catabolism in serum and platelet-poor plasma.
15. Poubelle PE, De Medecis R, Naccache PH: Monosodium urate and calcium pyrophosphate crystals differentially activate the excitation response coupling sequence of human neutrophils. Biochem Biophys Res Commun 1987, 149:649-657.
16. Naccache PH, Bourgoin S, Plante E, Roberge CJ, De Medecis R, Lussier A, Poubelle PE: Crystal induced neutrophil activation: II: evidence for the activation of phosphatidylcholine specific phospholipase D. Arthritis Rheum 1993, 1:117-125.
17. Onello E, Traynor-Kaplan A, Sklar L, Terkeltaub R: Mechanism of neutrophil activation by unopsonized inflammatory particulate: monosodium urate crystals induce pertussis toxin insensitive hydrolysis of phosphatidylinositol 4,5 biphosphate. J Immunol 1991, 146:4289-4294.
18. Gaudry M, Roberge CJ, De Medecis R, Lussier A, Poubelle PE, Naccache PH: Crystal induced neutrophil activation: III: inflammatory microcrystals induce a distinct pattern of tyrosine phosphorylation in human neutrophils. J Clin Invest 1993, 91:1649-1655.
19. Simchowitz L, Atkinson JP, Spilberg I: Stimulation of the respiratory burst in human neutrophils by crystal phagocytosis. Arthritis Rheum 1982, 25:181-188.
20. Roberge CJR, De Medecis JM, Rola-Pleszzynski M, Naccache PH, Poubelle PE: Crystal-induced neutrophil activation: V: differential production of biologically active IL-1 and II-1 receptor agonist. J Immunol 1994, 152:5485-5494.
21. Miller EJ, Brelsford WG: Interleukin-8: the major neutrophil chemotaxin in a case of pseudogout. J Rheumatol 1993, 20:1250-1252.
22. Hachicha M, Naccache PH, McColl SR: Inflammatory microcrystals differentially regulate the secretion of macrophage inflammatory protein 1 and interleukin 8 by human neutrophils: a possible mechanism of neutrophil recruitment to sites of inflammation in synovitis. J Exp Med 1995, 182:2019-2025. From a series of studies about microcrystals, inflammation, and interleukin-8, describing how interleukin-8 can lead to the recruitment of neutrophils but not mononuclear cells.
23. Swan A, Heywood B, Chapman B, Seward H, Dieppe P: Evidence for a causal relationship between the structure, size, and load of calcium pyrophosphate dihydrate crystals and attacks of pseudogout. Ann Rheum Dis 1995, 54:825-830. This is the first time that crystal characteristics have been related to pseudogout attacks based on examination of sequential synovial fluid samples from patients before and after a pseudogout attack.
24. Schumacher HR, Fishbein P, Phelps P, Tse R, Krauser R: Comparison of sodium urate and calcium pyrophosphate crystal size and other factors. Arthritis Rheum 1995, 18(suppl):783-793.
25. Watanabe W, Baker DG, Schumacher HR: Comparison of the acute inflammation induced by calcium pyrophosphate dihydrate, apatite and mixed crystals in the rat air pouch model of a synovial space. J Rheumatol 1992, 9:1453-1457.
26. Xu Y, Cruz TF, Cheng PT, Pritzker KPH: Effect of pyrophosphatase on dissolution of calcium pyrophosphate dihydrate crystals. J Rheumatol 1991, 18:66-71.
27. Xu Y, Cruz TF, Pritzker KPH: Alkaline phosphatase dissolves calcium pyrophosphate dihydrate crystals. J Rheumatol 1991, 18:1606-1610.
28. Rosenthal AK, Ryan LM: Probenecid inhibits transforming growth factor-β1 induced pyrophosphate elaboration by chondrocytes. J Rheumatol 1994, 21:896-900.
29. Cheung HS, Sallis JD, Struve JA: Specific inhibition of basic calcium phosphate and calcium pyrophosphate crystal induction of metalloproteinase synthesis. Biochim Biophys Acta 1996, 1315:105-111. An in vitro study about phosphocitrate and its ability to inhibit metalloproteinases, which cause the degenerative effects of CPPD crystals.
30. Van Linthoudt D, Salani I, Zender R, Locatelli P, Ott H, Schumacher HR: Citrate in synovial fluid and its relation to inflammation and crystal presence. J Rheumatol 1996, 23:3502-3505. This is the first study of citrate levels in synovial fluid. The results provide no support for an in vivo role of citrates in influencing the presence of calcium crystals in the synovial fluid.
31. Schumacher HR: Crystal induced arthritis: an overview. Am J Med 1996, 100(suppl):46-52.
32. Pascual E: The diagnosis of gout and CPPD crystal arthropathy. Br J Rheumatol 1996, 35:306-308.
33. Estepa-Maurice L, Hennequin C, Mafisi C, Barder C, Lacour B, Daudon M: Fourier transform infrared microscopy identification of crystal deposits in tissues: clinical importance and various pathologies. Am J Clin Pathol 1996, 105:576-582.
34. Pestaner J, Mullick F, Johnson F, Centeno J: Calcium oxalate crystals in human pathology: molecular analysis with the laser Raman microprobe. Arch Pathol Lab Med 1996, 120:537-540.
35. Blair JM, Sorensen LB, Arnsdorf HF, Lal R: The application of atomic force microscopy for the detection of microcrystals in synovial fluid from patients with recurrent synovitis. Semin Arthritis Rheum 1995, 24:359-369. This study included 33 patients with recurrent synovitis and proposes some advantages for atomic force microscopy over polarized light and electron microscopy for the detection of microcrystals.
36. Dicjkgraaf LC, De Bont LGM, Liem RSB: Calcium pyrophosphate dihydrate crystal deposition disease of the temporomandibular joint. J Oral Maxillofac Surg 1992, 50:1003-1009.
37. Magno WB, Lee SH, Schmidt J: Chondrocalcinosis of the temporomandibular joint: an external ear pseudotumor. Oral Surg Oral Med Oral Pathol 1992, 73:262-265.
38. Soto R, Takahashi M, Yamashita Y, Izunaga H, Skamoto Y, Yamamoto M, Sakae T: Calcium crystal deposition in cervical ligamentum flavum: CT and MRI findings. J Comput Assist Tomogr 1992, 16:1352-1355.
39. Sadique T, Bradley JG, Jackson AM: Central spinal stenosis due to pseudogout: a case report. J Bone Joint Surg Br 1994, 76:672-673.
40. Salcman M, Khan A, Symondo DA: Calcium pyrophosphate arthropathy of the spine: case report and review of the literature. Neurology 1994, 34:915-918.
41. Dijkgraaf LC, Liem RB, De Bont LG, Boering G: Calcium pyrophosphate dihydrate crystal deposition disease: a review of the literature and light electron microscopic study of a case of the temporomandibular joint with numerous intracellular crystals in the chondrocytes. Osteoarthritis Cartilage 1995, 3:35-45. A very interesting case report in which the authors suggest an intracellular pathway of CPPD crystal formation.
42. Brown TR, Qiunn SR, D'Agostino AN: Deposition of calcium pyrophosphate dihydrate crystals in the ligamentum flavum: evaluation with MR imaging and CT radiology. Radiology 1991, 178:871-873.
43. Markiewitz MD, Boumphry FR, Bauer TW, Bell GR: Calcium pyrophosphate dihydrate crystal deposition disease as a cause of lumbar canal stenosis. Spine 1996, 21:506-511. Description of the clinical presentation, the diagnostic and pathologic studies, and treatment of a large number of patients distributed in four different groups presenting with lumbar canal stenosis.
44. Fidler WK, Dewar CL, Fenton PV: Cervical spine pseudogout with myelopathy and Charcot joints. J Rheumatol 1996, 23:1445-1448.
45. Prudhommeaux F, Schiltz C, Liote F, Hina A, Champy R, Bucki B, Ortiz-Bravo E, Meunier A, Rey C, Bardin T: Variation in the inflammatory properties of basic calcium phosphate crystals according to crystal type. Arthritis Rheum 1996, 39:1319-1326. A careful examination of the different characteristics of BCP crystals and their ability to cause inflammation.
46. Verfaillie S, De Smet L, Lemans A, Van Damme B, Fabry G: Acute carpal tunnel syndrome caused by hydroxyapatite crystals: a case report J Hand Surg 1996, 21:360-362.
47. Marcos JC, Arturi AS, Babini C, Jimenez S, Knowlton R, Reginato AJ: Familial hydroxyapatite chondrocalcinosis with spondyloepiphyseal dysplasia: clinical course and absence of genetic linkage to the type II procollagen gene. J Clin Rheumatol 1996, 1:171-178. A very interesting 19-year follow-up describing families with hydroxyapatite chondrocalcinosis with spondyloepiphyseal dysplasia.
48. Szachnowski P, Bridges AJ: Subcutaneous cholesterol nodules [letter]. J Rheumatol 1994, 21:2391-2392.
49. Gur H, Ehrenfeld M: The benign long term effect of cholesterol crystal synovial cysts. Clin Rheumatol 1994, 13:537-542.
50. Moolenaar W, Lamers CBHW: Gastrointestinal blood loss due to cholesterol crystal embolization. J Clin Gastroenterol 1995, 21:220-223. Description and analysis of four cases of gastrointestinal blood loss due to cholesterol crystal embolization. An often unrecognized entity.
51. Ball NJ, Wickert W, Marx LH, Thaell JF: Crystalglobulinemia syndrome: a manifestation of multiple myeloma. Cancer 1993, 71:1231-1234.
52. Papo T, Musset L, Bardin T, Bucki B, Jorgensen C, Dion E, Quillard A, De Gennes C, Sany J, Godeau P, Piette JC: Cryocrystalglobulinemia as a cause of systemic vasculopathy and widespread erosive arthropathy. Arthritis Rheum 1996, 39:335-340. The report of a case and discussion of cryocrystalglobulinemia pathogenesis with therapeutic implications.